Crossmark

Clinical characteristics and satisfaction with the fimasartan in Korean hypertensive patients: a prospective, cross-sectional and open-label, 8-week switching study (Kanarb-hypertension epidemiology medication satisfaction study; K-HEMS study)

Crossref DOI link: https://doi.org/10.1186/s40885-018-0096-2

Published Online: 2018-09-01

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oh, Dong Joo

Han, Su-Eun

Jeong, Seung Hee

Hong, Myung Sook

Choe, Seong Choon https://orcid.org/0000-0002-8965-5227
Funding

Funding for this research was provided by:

Boryung Pharmaceutical Co. Ltd (NCT02394392)
License Information

Text and Data Mining valid from 2018-09-01
More Information

Article History

Received: 13 March 2018

Accepted: 20 July 2018

First Online: 1 September 2018

Ethics approval and consent to participate

: Institutional Review Board of participating institution approved the study design.

: Not applicable.

: SE Han, SH Jeong, MS Hong, and SC Choe are full-time employees of Boryung Pharmaceutical Co. Ltd.None of the authors were or will be compensated to discuss the findings from this study. The authors have indicated that they have no other conflicts of interest regarding the content of this article.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below